District Court: 340B Statute Isn’t Clear On Discounts Via Contract Pharmacies

By Michelle M. Stein / June 17, 2021 at 11:47 AM
The U.S. District Court for the District of Delaware on Wednesday (June 16) rejected the Biden administration’s request to dismiss AstraZeneca’s lawsuit challenging HHS’ effort to stop drug maker restrictions on 340B discounts on drugs dispensed via contract pharmacies, as the judge said the statue is vague on the issue. “Congress may very well want pharmaceutical manufacturers to deliver 340B drugs to an unlimited number of contract pharmacies as a condition for manufacturers’ participation in the Medicare Part B and...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.